Compagnie Lombard Odier S Cm A Orgenesis Inc. Transaction History

Compagnie Lombard Odier S Cm A

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 12, 2019	SELL	$4.18 - $4.85 $0 - $0	0 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.86 - $5.2 $0 - $0	0 New	0 $0

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.